Your browser doesn't support javascript.
loading
A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis.
Hung, Ivan Fan-Ngai; Yap, Desmond Yat-Hin; Yip, Terence Pok-Siu; Zhang, Ricky Ruiqi; To, Kelvin Kai-Wang; Chan, Kwok-Hung; Tang, Sydney Chi-Wai; Lui, Sing-Leung; Levin, Yotam; Kochba, Efrat; Lau, Johnson Yiu-Nam; Yuen, Man-Fung; Chan, Tak-Mao; Yuen, Kwok-Yung.
Afiliação
  • Hung IF; Division of Infectious Diseases, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Yap DY; Carol Yu's Centre for Infection and Division of Infectious Diseases, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Yip TP; Division of Nephrology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Zhang RR; Division of Nephrology, Department of Medicine, Tung Wah Hospital, Hong Kong Special Administrative Region, China.
  • To KK; Division of Infectious Diseases, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Chan KH; Carol Yu's Centre for Infection and Division of Infectious Diseases, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Tang SC; Carol Yu's Centre for Infection and Division of Infectious Diseases, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Lui SL; Carol Yu's Centre for Infection and Division of Infectious Diseases, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Levin Y; Division of Nephrology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Kochba E; Division of Nephrology, Department of Medicine, Tung Wah Hospital, Hong Kong Special Administrative Region, China.
  • Lau JY; NanoPass Technologies, Nes Ziona, Israel.
  • Yuen MF; NanoPass Technologies, Nes Ziona, Israel.
  • Chan TM; Carol Yu's Centre for Infection and Division of Infectious Diseases, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
  • Yuen KY; Division of Infectious Diseases, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
Clin Infect Dis ; 73(2): e304-e311, 2021 07 15.
Article em En | MEDLINE | ID: mdl-32556176
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 7 Toll-Like / Hepatite B Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 7 Toll-Like / Hepatite B Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China